4th Quarter - Report

CROSSROADS STRATEGIES, LLC for ALKERMES, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.2872, Opioid Addiction and Modernization Act; confronting the opioid and mental illness epidemic.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2872 (114th)

Alcohol and Drug Abuse ALC

S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 and Senate/H.R.2578, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2016; P.L.114-74, Bipartisan Budget Act of 2015; P.L.114-113, Consolidated Appropriations Act, 2016; advance the use of FDA-approved medicines to treat addiction in criminal justice and public health settings.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
ELIZABETH ALYSON HART —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3020 (114th), S. 1695 (114th), H.R. 2578 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.